Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients

SIMPLE SUMMARY: While latest evidence suggests that some patients with recurrent high-grade serous ovarian cancer may profit from reinduction with platinum-based chemotherapy regimens, the selection of patients who are likely to respond remains difficult. The present study therefore aimed to adapt a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartl, Thomas, Karacs, Jasmine, Kreuzinger, Caroline, Pfaffinger, Stephanie, Kendler, Jonatan, Ciocsirescu, Cristina, Wolf, Andrea, Reinthaller, Alexander, Meyer, Elias, Brandstetter, Maximilian, Postl, Magdalena, Langthaler, Eva, Braicu, Elena, Vergote, Ignace, Cunnea, Paula, Gourley, Charlie, Schmitt, Wolfgang D., Cacsire Castillo-Tong, Dan, Christoph, Grimm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959281/
https://www.ncbi.nlm.nih.gov/pubmed/33802395
http://dx.doi.org/10.3390/cancers13051076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959281/
https://www.ncbi.nlm.nih.gov/pubmed/33802395
http://dx.doi.org/10.3390/cancers13051076

Ejemplares similares